Precision BioSciences
DTIL
134 hedge funds and large institutions have $233M invested in Precision BioSciences in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 24 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 30
2% more funds holding
Funds holding: 132 → 134 (+2)
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
7% more call options, than puts
Call options by funds: $567K | Put options by funds: $530K
0.1% more ownership
Funds ownership: 1.63% → 1.73% (+0.1%)
31% less capital invested
Capital invested by funds: $337M → $233M (-$103M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.84M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.72M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.65M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.27M |
| 5 |
BlackRock
New York
|
+$1.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.97M |
| 2 |
Two Sigma Investments
New York
|
-$2.21M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.08M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.89M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.73M |
DTIL Hedge Fund Activity: Q4 2021 in Review
134 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2021, worth a combined $233M — down 31% from $337M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new DTIL positions and 24 closed out — a net gain of 2 holders — while 48 added to existing stakes and 30 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $2.84M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $3.97M.
- 134 institutional investors held Precision BioSciences (DTIL) as of Q4 2021, up from 132 in Q3 2021.
- Funds reported $233M of Precision BioSciences stock for Q4 2021, down 31% quarter-over-quarter.
- 26 funds opened new Precision BioSciences positions in Q4 2021 and 24 closed out, a net change of +2 holders.
- The largest Precision BioSciences buyer in Q4 2021 was Goldman Sachs, an estimated $2.84M added.
- The largest Precision BioSciences seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $3.97M sold.
Based on aggregated 13F filings for Q4 2021.